Skip to main content

The rockefeller university

Calendar of Events & Lectures

Displaying 2 of 3482 events.
Calendar. Can be used to select a date
Previous monthSeptember 2024Next month
SunMonTueWedThuFriSat
25262728293031
1234567
891011121314
15161718192021
22232425262728
293012345
Today
This Week

Friday, September 6, 2024

Anderson Center for Cancer Research Poster Session

| LOWER LEVEL GREENBERG BUILDING (CRC)
Lectures and Symposia, Academic Symposia

Anderson Center for Cancer Research Symposium

| CASPARY AUDITORIUM
Lectures and Symposia, Academic Symposia
André Nussenzweig, Ph.D., chief, Laboratory of Genome Integrity, National Institutes of Health National Cancer Institute
Sara Wickström, M.D., Ph.D., director and scientific member, Max Planck Institute for Molecular Biomedicine
Andrew Jackson, Ph.D., programme leader, Medical Research Council Human Genetics Unit, University of Edinburgh
Scott Lowe, Ph.D., chair, Cancer Biology and Genetics Program, Sloan Kettering Institute, chair, Geoffrey Beene Cancer Research Center, Memorial Sloan Kettering Cancer Center, Howard Hughes Medical Institute

Tri-Institutional Calendars

The close proximity among the three institutions which comprise the Tri-I has led to a culture that encourages interinstitutional interactions and shared resources, including access to lectures and seminars from internationally renowned scientists and clinicians:

Upcoming Events

Lipid Therapy: A Novel Therapeutic Strategy Utilizing Low-density Lipoproteins Against Cancer

| AUDITORIUM, ROCKEFELLER RESEARCH LABORATORIES, MSKCC, 430 E. 67TH ST.

The Tapestry of Human Prenatal Immunity

| 105 ZRC, MSKCC, 417 E. 68TH ST.

Dysregulated Nucleic Acid Sensing and Type I Interferons in Chronic Inflammation.

| 301 WRB

News

Rockefeller startup aims to change the course of treatment for severe autoimmune diseases

Nuvig, a biotech company cofounded by Jeffrey Ravetch, has launched phase two trials and raised $200 million.

Researchers develop a potential IVIG replacement for treating autoimmunity that’s significantly more potent

The discovery could greatly improve patient experience and address supply shortages.

This immune circuit may protect the brain from Alzheimer's

A newly identified molecular pathway shifts microglia into a protective state, and may lead to Alzheimer's therapies that can reprogram the brain’s own immune defenses.

Room Reservation Calendar(opens in new window)